4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001140361-18-000538
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
- Director acquired 1,184 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIRK RANDAL J Director | 2017-12-29 | Grant or award · Option to Purchase Common Stock | +25,000 | 25,000 | D: show line 1 in the form | ||
| KIRK RANDAL J Director | 2017-12-29 | Other acquisition · Series 1 Preferred Stock | +1,184 | 119,644 | I: show line 2 in the form |
Loading xslF345X03/doc1.xml…